Edith M. Lord, Ph.D.

Contact Information

Biography

Professional Background

Dr. Edith Lord is a Professor of Microbiology & Immunology and Oncology. Dr. Lord received her BA degree in microbiology from the University of Kansas in 1970 and a Ph.D degree in immunology from the University of California at San Diego in 1975. She was a postdoctoral fellow at the University of California at San Francisco. As a faculty member since 1976, Dr. Lord has demonstrated excellence as a scientist and dedication to the training of graduate students and postdoctoral fellows.

From 2006-2008, Dr. Lord led the graduate program in the Department of Microbiology and Immunology. She was the Senior Associate Dean for Graduate Education and Postdoctoral Affairs at the School of Medicine and Dentistry from 2008-2018.

In her research, Dr. Lord focuses on the immune responses that can control tumor development and how immune cells function within the unique microenvironment of growing tumors. She has published, as author and co-author, more than 130 scientific articles and continues her passion for research today.

Credentials

Education

1970
BA | University of Kansas
Microbiology

1975
PhD | Univ of Cal San Diego
Immunology

Awards

2018
Graduate Student Society Advocacy Award

Patents

Patent Title: Serum Free Cell Culture Medium
Patent #: 4,816,401
Issue Date: Mar 28, 1989
Country: United States
Invented By: Edith M Lord

Patent Title: Monoclonal Antibodies Differentially Reactive with Native and Reductively Modified Bowman-Birk Protease Inhibitor
Patent #: 5,616,492
Issue Date: Apr 01, 1997
Country: United States
Invented By: Ann R Kennedy, Cameron J Koch, Edith M Lord, Xingsheng Wan

Patent Title: Method of Monitoring Exposure to Bowman Birk Inhibitor Using Monoclonal Antibodies Against Bowman Birk Inhibitor Metabolites
Patent #: 5,618,679
Issue Date: Apr 08, 1997
Country: United States
Invented By: Ann R Kennedy, Cameron J Koch, Edith M Lord, Xingsheng Wan

Patent Title: Detection of Hypoxia with Reagents Containing 2-Nitroimidazole Compounds and Methods of Making such Reagents.
Patent #: 5,540,908
Issue Date: Jul 30, 1996
Country: United States
Invented By: Cameron J Koch, Edith M Lord

Patent Title: Detection of Hypoxia
Patent #: 5,843,404
Issue Date: Dec 01, 1998
Country: United States
Invented By: Cameron J Koch, Edith M Lord

VIEW ALL

Publications

Journal Articles

7/26/2023
Uccello TP, Lesch ML, Kintzel SA, Gradzewicz LB, Lamrous L, Murphy SP, Fleming FJ, Mills BN, Murphy JD, Hughson A, Hannon G, Garrett-Larsen J, Qiu H, Drage MG, Ye J, Gavras NW, Keeley DC, Love TMT, Repasky EA, Lord EM, Linehan DC, Gerber SA. "New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy." Cell death & disease.. 2023 Jul 26; 14(7):470. Epub 2023 Jul 26.

5/2023
Ye J, Gavras NW, Keeley DC, Hughson AL, Hannon G, Vrooman TG, Lesch ML, Johnston CJ, Lord EM, Belt BA, Linehan DC, Eyles J, Gerber SA. "CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models." Journal for immunotherapy of cancer.. 2023 May; 11(5)

10/3/2022
Uccello TP, Lecsh ML, Ullman NA, Kintzel SA, Gradzewicz LB, Velagaleti T, Fleming FJ, Mills BN, Murphy JD, Garrett-Larsen J, Qiu H, Drage MG, Ye J, Gavras NW, Johnston CJ, Love TMT, Repasky EA, Linehan DC, Lord EM, Gerber SA. "Radiotherapy exacerbates tumor-promoting innervation and nerve signaling in rectal cancer." International journal of radiation oncology, biology, physics.. 2022 Oct 3; Epub 2022 Oct 03.

VIEW ALL PUBLICATIONS